YWM
AVXL icon

Yukon Wealth Management’s Anavex Life Sciences AVXL Stock Holding History

Yukon Wealth Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.2K Buy
13,992
+1,947
+16% +$5.76K 0.01% 132
2026
Q1 		$37K Sell
12,045
-6,000
-33% -$26K 0.02% 79
2025
Q4 		$74.5K Buy
18,045
+1,053
+6% +$6.45K 0.04% 81
2025
Q3 		$151K Sell
16,992
-157
-0.9% -$1.59K 0.05% 127
2025
Q2 		$158K Hold
17,149
– – 0.06% 116
2025
Q1 		$147K Buy
+17,149
New +$162K 0.06% 102

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Yukon Wealth Management's AVXL Position: Q2 2026 in Review

Yukon Wealth Management increased its Anavex Life Sciences (AVXL) stake by 16% in Q2 2026, buying an estimated $5.76K and bringing the position to 13,992 shares worth $36.2K. The position accounts for 0.01% of the portfolio, ranked #132.

Yukon Wealth Management first reported a position in AVXL in Q1 2025 and has held it in 6 quarters since. The position peaked at $158K in Q2 2025. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Yukon Wealth Management held 13,992 shares of Anavex Life Sciences worth $36.2K as of Q2 2026.
  • Yukon Wealth Management bought 1,947 Anavex Life Sciences shares in Q2 2026, an estimated $5.76K.
  • Anavex Life Sciences made up 0.01% of Yukon Wealth Management's portfolio in Q2 2026, its #132 holding.
  • Yukon Wealth Management first reported a position in Anavex Life Sciences in Q1 2025 and has held it in 6 quarters since.
  • Yukon Wealth Management's Anavex Life Sciences position peaked at $158K in Q2 2025.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Yukon Wealth Management's 13F filing for Q2 2026, filed 17 Aug 2026.